Biological function and exercise regulation of high-density lipoprotein

doi:10.3969/j.issn.2095-4344.2015.37.026

Abstract

Abstract:

BACKGROUND: High-density lipoprotein is related to lipid metabolism, but its function cannot be restricted to the scope of lipid metabolism. Simultaneously, exercise regulation has effects on the activity and amount of high-density lipoprotein, but the optimal movement pattern needs to be studied.

OBJECTIVE: To offer the theoretical support for formulating fitness training and prospect the possible direction and reference in follow-up studying the biological function and exercise regulation of high-density lipoprotein.

METHODS: PubMed database was searched for relevant articles published from 1990 to 2015 using the keywords of “HDL and exercise, HDL and biological function” in English. Finally, 44 articles were included in result analysis.

RESULTS AND CONCLUSION: The biological functions of high-density lipoprotein mainly include high-density lipoprotein-mediated metabolism of glucose, protein and fat, anti-inflammation, antioxidation and insulin secretion, and at the same time, we summarize the effects of exercise on the concentration, numbers of molecular and components of high-density lipoprotein. The results indicate that the combination of resistance and endurance training is the best way for raising the concentration and functional effects of high-density lipoprotein.

中国组织工程研究杂志出版内容重点：组织构建；骨细胞；软骨细胞；细胞培养；成纤维细胞；血管内皮细胞；骨质疏松；组织工程

Key words: Tissue Engineering, Lipoproteins, HDL, Metabolism, Proteins

CLC Number:

R318

Su Zhong-jun, Zhang Su, Jiang Jun. Biological function and exercise regulation of high-density lipoprotein[J]. Chinese Journal of Tissue Engineering Research, 2015, 19(37): 6048-6054.

Figures/Tables 2

References

[1] Remaley AT, Rust S, Rosier M, et al. Human atp-binding cassette transporter 1 (abc1) genomic organization and identification of the genetic defect in the original tangier disease kindred. PNAS. 1999;96:12685-12690.

[2] Kennedy MA, Barrera GC, Nakamura K, et al. Abcg1 has a critical role in mediating cholesterol efflux to hdl and preventing cellular lipid accumulation. Cell Metab. 2005;1(2): 121-131.

[3] Varma V, Yao-Borengasser A, Rasouli N, et al. Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action. Am J Physiol Endocrinol Metab. 2009; 296:E1300-E1310.

[4] Hotamisligil GS, Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol. 2008;8(12):923-934.

[5] Montell El, Turini M, Marotta M. Dag accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells. Am J Physiol Endocrinol Metab. 2001; 280:E229-E237.

[6] Samokhvalov VPJB, Jonathan D. Palmitate- and lipopolysaccharide-activated macrophages evoke contrasting insulin responses in muscle cells. Am J Physiol Endocrinol Metab. 2009;296:E37-E46.

[7] Drew BG, Duffy SJ, Formosa MF, et al. High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus. Circulation. 2009;119(15): 2103-2111.

[8] Zhang Y, McGillicuddy FC, Hinkle CC, et al. Adipocyte modulation of high-density lipoprotein cholesterol. Circulation. 2010;121(11):1347-1355.

[9] Schimmack G, Defronzo RA, Musi N. Amp-activated protein kinase: role in metabolism and therapeutic implications. Diabetes Obes Metab. 2006;8(6):591-602.

[10] Zhou G, Myers R, Li Y, et al. Role of amp-activated protein kinase in mechanism of metformin action.J Clin Invest. 2001; 108(8):1167-1174.

[11] Kemp BE, Mitchelhill KI, Stapleton D, et al. Dealing with energy demand the amp-activated protein kinase. Trends Biochem Sci. 1999;24:22-25.

[12] Han R, Lai R, Ding Q, et al. Apolipoprotein a-i stimulates amp-activated protein kinase and improves glucose metabolism. Diabetologia. 2007;50(9):1960-1968.

[13] Ruan X, Li Z, Zhang Y. et al. Apolipoprotein a-i possesses an anti-obesity effect associated with increase of energy expenditure and up-regulation of ucp1 in brown fat. J Cell Mol Med. 2011;15(4):763-772.

[14] Li J, Murao K, Imachi H, et al. Exendin-4 regulates pancreatic abca1 transcription via camkk/camkiv pathway. J Cell Mol Med. 2010;14(5):1083-1087.

[15] Drew BG, Fidge NH, Gallon-Beaumier G, et al. High-density lipoprotein and apolipoprotein ai increase endothelial no synthase activity by protein association and multisite phosphorylation. Proc Natl Acad Sci U S A. 2004;101(18): 6999-7004.

[16] Adams V, Besler C, Fischer T, et al. Exercise training in patients with chronic heart failure promotes restoration of high-density lipoprotein functional properties. Circ Res. 2013;113(12): 1345-1355.

[17] Cockerill GW, Huehns TY, Weerasinghe A, et al. Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of e-selectin in an in vivo model of acute inflammation. Circulation. 2001;103(1):108-112.

[18] Barter PJ, Baker PW, Rye KA. Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells. Curr Opin Lipidol. 2002;13:285-288.

[19] Nofer JR, Geigenmüller S, Göpfert C, et al. High density lipoprotein-associated lysosphingolipids reduce e-selectin expression in human endothelial cells. Biochem Biophys Res Commun. 2003;310(1):98-103.

[20] Barter PJ, Nicholls S, Rye KA, et al. Antiinflammatory properties of hdl. Circ Res. 2004;95(8):764-772.

[21] Okura HYS, Ohama T, Saga A, et al. Hdl apolipoprotein a-i binds to macrophage-derived progranulin and suppresses its conversion into proinflammatory granulins. J Atheroscler Thromb. 2010;17(6):568-577.

[22] Yamagishi SHA, Matsui T. Decreased high-density lipoprotein cholesterol level is an independent correlate of circulating tumor necrosis factor-alpha in a general population. Clin Cardiol. 2009; 32(9):E29-E32.

[23] Ibanez B, Giannarelli C, Cimmino G, et al. Recombinant hdl (milano) exerts greater anti-inflammatory and plaque stabilizing properties than hdl (wild-type). Atherosclerosis. 2012;220(1):72-77.

[24] Lowenstein CJ, Cameron SJ.High-density lipoprotein metabolism and endothelial function. Curr Opin Endocrinol Diabetes Obes. 2010;17(2):166-170.

[25] Orlov SV, Mogilenko DA, Shavva VS, et al. Effect of tnfalpha on activities of different promoters of human apolipoprotein a-i gene. Biochem Biophys Res Commun. 2010;398(2):224-230.

[26] Bursill CA, Castro ML, Beattie DT, et al. High-density lipoproteins suppress chemokines and chemokine receptors in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2010;30(9): 1773-1778.

[27] Murphy AJ, Woollard KJ, Hoang A, et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol. 2008;28(11): 2071-2077.

[28] Bowry VW, Stanley KK, Stocker R. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci USA. 1992;89:10316-10320.

[29] Navab M, Hama SY, Cooke CJ, et al. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein step 1. J Lipid Res. 2000;41:1481-1494.

[30] Valiyaveettil M, Kar N, Ashraf MZ, et al. Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI. Blood Coagul Fibrinolysis. 2008;111(4): 1962-1971.

[31] Benjamin J, Ansell GCF, Alan M. Fogelman.The paradox of dysfunctional high-density lipoprotein.Curr Opin Lipidol. 2007; 18:427-434.

[32] Proudfoot JM, Barden AE, Loke WM, et al. Hdl is the major lipoprotein carrier of plasma f2-isoprostanes. J Lipid Res. 2009; 50(4):716-722.

[33] Brunham LR, Kruit JK, Pape TD, et al. Beta-cell abca1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment. Nat Med. 2007;13(3):340-347.

[34] Fryirs MA, Barter PJ, Appavoo M, et al. Effects of high-density lipoproteins on pancreatic beta-cell insulin secretion. Arterioscler Thromb Vasc Biol. 2010;30(8): 1642-1648.

[35] Hao M, Head WS, Gunawardana SC, et al. Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction. Diabetes. 2007;56(9): 2328-2338.

[36] Vikman J, Jimenez-Feltstrom J, Nyman P, et al. Insulin secretion is highly sensitive to desorption of plasma membrane cholesterol. FASEB J. 2009;23(1):58-67.

[37] Barzegari A, Amouzad Mahdirejei H.. Effects of 8 weeks resistance training on plasma vaspin and lipid profile levels in adult men with type 2 diabetes. Caspian J Intern Med. 2014;5(2): 103-108.

[38] Perez-Gomez J, Vicente-Rodriguez G, Ara Royo I, et al. Effect of endurance and resistance training on regional fat mass and lipid profile. Nutr Hosp. 2013;28(2):340-346.

[39] Paoli AQ, Moro T, Marcolin G, et al. Effects of high-intensity circuit training, low-intensity circuit training and endurance training on blood pressure and lipoproteins in middle-aged overweight men. Lip Health Dis. 2013;12:131.

[40] So WY, Song M, Park YH, et al. Body composition, fitness level, anabolic hormones, and inflammatory cytokines in the elderly: a randomized controlled trial. Aging Clin Exp Res. 2013;25(2): 167-174.

[41] Lee MG, Park KS, Kim DU, et al. Effects of high-intensity exercise training on body composition, abdominal fat loss, and cardiorespiratory fitness in middle-aged korean females. Appl Physiol Nutr Metab. 2012;37(6):1019-1027.

[42] Sondergaard E, Poulsen MK, Jensen MD, et al. Acute changes in lipoprotein subclasses during exercise. Metabolism. 2014; 63(1):61-68.

[43] Casella-Filho A, Chagas AC, Maranhao RC, et al. Effect of exercise training on plasma levels and functional properties of high-density lipoprotein cholesterol in the metabolic syndrome. Am J Cardiol. 2011;107(8):1168-1172.

[44] Tseng ML1, Ho CC, Chen SC, et al. A simple method for increasing levels of high-density lipoprotein cholesterol a pilot study of combination aerobic-and resistance-exercise training. Int J Sport Nutr Exerc Metab. 2013;23:271-281.

[45] Wellen KE. Inflammation, stress, and diabetes. J Clin Invest. 2005;115(5):1111-1119.

[46] Hardardottie IMA, Memon R. Effects of tnf, il-1, and the combination of both cytokines on cholesterol metabolism in syrian hamsters. Lymphokine Cytokine Res. 1994;13: 161-166.

[47] Blazek A, Rutsky J, Osei K, et al. Exercise-mediated changes in high-density lipoprotein: Impact on form and function. Am Heart J. 2013;166(3):392-400.

[48] Kelley GA, aKelley KS. Impact of progressive resistance training on lipids and lipoproteins in adults: A meta-analysis of randomized controlled trials. Prev Med. 2009;48(1):9-19.

[49] Hornbuckle LM, Liu PY, Ilich JZ, et al. Effects of resistance training and walking on cardiovascular disease risk in african- american women. Med Sci Sports Exerc. 2012;44(3):525-533.

[50] Drew BG, Rye KA, Duffy SJ, et al. The emerging role of hdl in glucose metabolism. Nat Rev Endocrinol. 2012;8(4):237-245.

[51] Tolle M, Huang T, Schuchardt M, et al. High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A. Cardiovasc Res. 2012;94(1):154-162.

[52] Terasaka N, Yu S, Yvan-Charvet L, et al. Abcg1 and hdl protect against endothelial dysfunction in mice fed a high-cholesterol diet. J Clin Invest. 2008;118(11):3701-3713.

[53] Briand F, Prunet-Marcassus B, Thieblemont Q, et al. Raising hdl with cetp inhibitor torcetrapib improves glucose homeostasis in dyslipidemic and insulin resistant hamsters. Atherosclerosis. 2014;233(2):359-362.